Results 111 to 120 of about 91,224 (305)

Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study

Transplant Infectious Disease, EarlyView.
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon, Merle Sophie Kaiser, Marcus Bachmann, Gérard Krause, Jens Gottlieb   +4 more
wiley   +1 more source

Current Practice Patterns and Educational Needs of the ESCMID Study Group for Infections in Compromised Hots

Transplant Infectious Disease, EarlyView.
The ESGICH survey highlights variability in training and support for Immunocompromised Host Infectious Diseases (ICH‐ID). Respondents expressed strong interest in structured education, research collaboration, and certification, underscoring the need for targeted initiatives to strengthen expertise, improve patient care, and define ICH‐ID as a ...
Maddalena Giannella, Daniele Riccucci, Renato Pascale, Elisa Cordero, Nicolas J. Mueller, Monica Slavin, Michael Ison, the ECCMID study groups on Invasive Fungal Infection and Infection in Immunocompromised Hosts   +7 more
wiley   +1 more source

Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients

Transplant Infectious Disease, EarlyView.
A novel regimen of sulfamethoxazole/trimethoprim single strength one tablet twice weekly for Pneumocystis jiroveci Pneumonia (PJP) prophylaxis in lung transplant patients found no cases of PJP over an 8‐year period and may reduce the incidence of medication discontinuation due to adverse effects. ABSTRACT Background Pneumocystis jiroveci pneumonia (PJP)
Chloe Munroe, Alissa Chan, Morgan Eiting, Bhanupriya Sirandas, Crystal Truax, Lonnie Smith, Matthew Morrell, Todd Larson, Kelsea Zukauckas   +8 more
wiley   +1 more source

Pichia anomala:cell physiology and biotechnology relative to other yeasts [PDF]

, 2010
Pichia anomala is a most interesting yeast species, from a number of environmental, industrial and medical aspects. This yeast has been isolated from very diverse natural habitats (e.g.
Walker, Graeme M.
core   +2 more sources

Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.

Cochrane Database of Systematic Reviews, 2015
BACKGROUND Pneumocystis jiroveci pneumonia (PCP) remains the most common opportunistic infection in patients infected with the human immunodeficiency virus (HIV).
Hannah Ewald, H. Raatz, R. Boscacci, H. Furrer, H. Bucher, M. Briel   +5 more
semanticscholar   +1 more source

The first live term birth following uterus transplantation in Australia

Medical Journal of Australia, EarlyView.
Abstract Objective To report the first live birth following uterus transplantation in Australia. Study design Case report. Setting, participant The first participant in the uterus transplantation research study program at the Royal Hospital for Women, the Prince of Wales Hospital, and Westmead Hospital in Sydney.
Rebecca Deans, Brigitte Gerstl, Antonia W Shand, Sarah Lyons, Aaron Budden, Helen L Barrett, Grant Luxton, Mangalee Fernando, Kenneth Yong, Karen Keung, Kaushalya Arulpragasam, Henry Pleass, King Man Wan, Eva Kehag, Jana‐Emily Pittman, Mianna Lotz, Maria Fenn, Erin Nesbitt‐Hawes, Lily Byun, Katrina Tang, Mats Brannstrom, Jason Abbott   +21 more
wiley   +1 more source

Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages

BMC Microbiology, 2010
Background Pneumocystis pneumonia is a common opportunistic disease in AIDS patients. The alveolar macrophage is an important effector cell in the clearance of Pneumocystis organisms by phagocytosis.
Liao Chung-Ping, Xuei Xiaoling, Liu Yunlong, Cheng Bi-Hua, Lu Debao, Lasbury Mark E, Durant Pamela J, Lee Chao-Hung   +7 more
doaj   +1 more source

Efficacy and Safety of Bendamustine‐Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma

European Journal of Haematology, Volume 115, Issue 3, Page 260-265, September 2025.
ABSTRACT Introduction Bendamustine‐rituximab (BR) has demonstrated efficacy and tolerability in the treatment of various indolent B‐cell lymphomas, but there is limited data regarding its outcomes in nodular lymphocyte predominant B‐cell (Hodgkin) lymphoma (NLPBL).
Alexander Robin, Carolyn Owen, Sarah Perry, Lesley Street, Neil Chua, Douglas Stewart, Robert Puckrin   +6 more
wiley   +1 more source

CD19 chimeric antigen receptor T‐cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapy

British Journal of Haematology, EarlyView.
Angela Hwang, Amy A. Kirkwood, Maeve O'Reilly, Lorna Neill, Caroline Besley, Shankara Paneesha, Mathew Amrith, Paul Maciocia, Andrea Kuhnl, David Irvine, Jane Norman, Ahmed Abdulgawad, Carlos Gonzalez Arias, Sunil Iyengar, Helen Marr, Satyen Gohil, Claire Roddie   +16 more
wiley   +1 more source

Safety Evaluation of Serendipity Berry Sweet Protein From Komagataella phaffii

Journal of Applied Toxicology, Volume 45, Issue 8, Page 1455-1475, August 2025.
ABSTRACT Serendipity Berry Sweet Protein (sweelin) is a novel hyper‐sweet thermophilic protein designed using Artificial Intelligence Computational Protein Design (AI‐CPD) to improve the stability and sensory profile of the protein found in serendipity berry (Dioscoreophyllum cumminsii).
Yael Lifshitz, Shira Paz, Rotem Saban, Inbar Zuker, Hagay Shmuely, Katy Gorshkov, Jwar Meetro, Shahrzad Tafazoli, Trung Vo, Gabriela Amiram, Carmit Shani Levi, Uri Lesmes, Ilan Samish   +12 more
wiley   +1 more source